Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sabinsa's ForsLean protected

This article was originally published in The Tan Sheet

Executive Summary

Sabinsa prevails with an appellate court ruling that Creative Compounds' Forsthin brand infringed on the nutritional supplement ingredient supplier's ForsLean trademark. The East Windsor, N.J., firm said July 14 the Third Circuit U.S. Court of Appeals reversed a federal district court judgment in favor of Creative Compounds and ordered a judgment entered in favor of Sabinsa without a new trial. According to the ruling, Sabinsa first marketed ForsLean (coleus forskohlii) to manufacturers in 2000 as an ingredient to promote lean body mass and later created pamphlets marketing the ingredient directly to consumers. Scott City, Mo.-based Creative Compounds began selling its forskohlin product in 2002, but did not adopt the brand Forsthin until the spring of 2004, prompting a cease-and-desist letter from Sabinsa. Sabinsa in 2007 retained exclusive U.S. proprietary rights to ForsLean with a U.S. district court patent infringement judgment against DNP International (1"The Tan Sheet" July 9, 2007, In Brief)
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS104320

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel